Phase II, two-stage study of avelumab in patients with microsatellite stable (MSS), microsatellite instable (MSI) and polymerase epsilon (POLE) mutated recurrent or persistent endometrial cancer

Subjects

Subjects :

0301 basic medicine
biology
business.industry
Endometrial cancer
Obstetrics and Gynecology
medicine.disease
Avelumab
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
Microsatellite Stable
030220 oncology & carcinogenesis
medicine
biology.protein
Cancer research
Microsatellite
In patient
Stage (cooking)
business
Polymerase
medicine.drug

Details

ISSN :

00908258

Volume :

149

Database :

OpenAIRE

Journal :

Gynecologic Oncology

Accession number :

edsair.doi...........6ec903c2ea0a0b33e7831542d9144485

Full Text :

https://doi.org/10.1016/j.ygyno.2018.04.060